Ocular Therapeutix, Inc. (OCUL)

$8.98 -0.66% $-0.06 Healthcare

Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cataract surgery; and DEXTENZA, a dexamethasone ophthalmic insert to treat post-surgical ocular inflammation and pain following ophthalmic surgery, as well as allergic conjunctivitis. It is also developing OTX-TKI, an axitinib intravitreal implant that is in phase 1 clinical trials for the treatment of wet age-related macular degeneration and other retinal diseases; OTX-TIC, a travoprost intracameral implant, which is in phase 2 clinical trials for the treatment of open-angle glaucoma or ocular hypertension; OTX-CSI, a cyclosporine intracanalicular insert that has completed phase 2 clinical trials for the treatment of dry eye disease; and OTX-DED, a dexamethasone intracanalicular insert, which is in phase 2 clinical trials for the short-term treatment of the signs and symptoms of dry eye disease. The company has a strategic collaboration with Regeneron Pharmaceuticals, Inc. (Regeneron) for the development and commercialization of products using the Company's sustained-release hydrogel in combination with Regeneron's large molecule VEGF-targeting compounds for the treatment of retinal diseases; and AffaMed Therapeutics Limited for the development and commercialization of DEXTENZA and OTX-TIC, as well as a discovery collaboration with Mosaic Biosciences to identify new targets and therapeutic agents for the treatment of dry age-related macular degeneration (dMAD). Ocular Therapeutix, Inc. was incorporated in 2006 and is headquartered in Bedford, Massachusetts.

$1.40B

Mr. Antony Mattessich

228.00

Bedford, MA

Jul 25, 2014

-8.24

$-1.09

15.34

16.64

-227.16%

-10.83

-0.30

3.97

23.14

16.55

-26.76%

-62.56%

Similar stocks (11)

Day One Biopharmaceuticals, Inc.

DAWN

$14.78 3.21%
Downtrend

Terns Pharmaceuticals, Inc.

TERN

$10.02 -0.20%
Uptrend

Inozyme Pharma, Inc.

INZY

$5.73 -0.87%
Uptrend

Amylyx Pharmaceuticals, Inc.

AMLX

$3.10 7.64%
Downtrend

HOOKIPA Pharma Inc.

HOOK

$4.74 0.42%
Downtrend

Acumen Pharmaceuticals, Inc.

ABOS

$2.50 -3.10%
Downtrend

Assembly Biosciences, Inc.

ASMB

$19.43 5.03%
Uptrend

X4 Pharmaceuticals, Inc.

XFOR

$0.71 -0.08%
Downtrend

PDS Biotechnology Corporation

PDSB

$3.20 -0.31%
Downtrend

CytomX Therapeutics, Inc.

CTMX

$1.19 1.71%
Downtrend

Spero Therapeutics, Inc.

SPRO

$1.33 -1.85%
Downtrend

ETF Exposure (28)

Direxion Daily Pharmaceutical & Medical Bull 3X Shares ETF

PILL

2.1603904289%

$8.43 -2.43%
Uptrend

iShares Micro-Cap ETF

IWC

0.3515%

$124.41 -1.68%
Uptrend

Invesco Nasdaq Biotechnology ETF

IBBQ

0.131%

$24.43 -0.93%
Uptrend

iShares Russell 2000 Growth ETF

IWO

0.10358%

$284.14 -0.57%
Uptrend

Vanguard Russell 2000 Growth Index Fund

VTWG

0.1%

$206.87 -0.69%
Uptrend

Vanguard U.S. Momentum Factor ETF

VFMO

0.07%

$160.50 -0.61%
Uptrend

iShares Russell 2000 ETF

IWM

0.05142%

$221.63 -1.04%
Uptrend

Vanguard Russell 2000 Index Fund

VTWO

0.05%

$89.66 -1.02%
Uptrend

ProShares Ultra Nasdaq Biotechnology

BIB

0.03771457457525115%

$66.96 -1.86%
Uptrend

Vanguard Extended Market Index Fund Institutional Shares

VIEIX

0.02%

$138.77 2.02%
Uptrend

Vanguard Extended Market Index Fund

VXF

0.02%

$181.66 -0.69%
Uptrend

ProShares Ultra Russell2000

UWM

0.019454244274121374%

$43.12 -2.20%
Uptrend

Fidelity MSCI Health Care Index ETF

FHLC

0.01378587%

$73.21 -0.39%
Uptrend

Vanguard Health Care Index Fund

VHT

0.01%

$285.06 -0.49%
Uptrend

ProShares UltraPro Russell2000

URTY

0.00958802645044285%

$52.47 -3.32%
Uptrend

ProShares Hedge Replication ETF

HDG

0.008151318480323898%

$50.11 0.08%
Uptrend

iShares Core S&P Total U.S. Stock Market ETF

ITOT

0.0028%

$124.94 -0.25%
Uptrend

iShares Russell 3000 ETF

IWV

0.00265%

$324.77 -0.26%
Uptrend

Goldman Sachs ActiveBeta U.S. Small Cap Equity ETF

GSSC

0%

$69.37 -1.21%
Uptrend

Vanguard Balanced Index Fund Institutional Shares

VBAIX

0%

$49.96 1.07%
Uptrend

Vanguard Balanced Index Fund Admiral Shares

VBIAX

0%

$49.95 1.07%
Uptrend

Vanguard Balanced Index Fund

VBINX

0%

$49.94 1.05%
Uptrend

Vanguard Institutional Total Stock Market Index Fund Institutional Shares

VITNX

0%

$97.80 1.74%
Uptrend

Vanguard Institutional Total Stock Market Index Fund

VITPX

0%

$97.78 1.74%
Uptrend

Vanguard Total Stock Market Index Fund

VITSX

0%

$137.33 1.73%
Uptrend

Vanguard Russell 3000 Index Fund

VTHR

0%

$252.39 -0.26%
Uptrend

Vanguard Total Stock Market Index Fund

VTI

0%

$281.42 -0.22%
Uptrend

Vanguard Total Stock Market Index Fund

VTSAX

0%

$137.30 1.73%
Uptrend